|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.12 USD | -3.50% |
|
-2.71% | +9.03% |
| 29/06 | Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index | CI |
| 29/06 | Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index | CI |
| Market Cap | 4.77B 4.18B 3.86B 3.55B 6.71B 460B 6.81B 46.21B 18.11B 225B 17.91B 17.52B 775B | P/E 2026 * |
12.3x | P/E 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.82B 4.23B 3.91B 3.59B 6.78B 465B 6.89B 46.73B 18.32B 228B 18.11B 17.72B 784B | EV / Sales 2026 * |
3.83x | EV / Sales 2027 * | 3.33x |
| Free-Float |
97.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -3.50% | ||
| 1 week | -2.71% | ||
| Current month | -4.66% | ||
| 1 month | +2.14% | ||
| 3 months | +20.67% | ||
| 6 months | +18.73% | ||
| Current year | +9.03% |
| 1 week | 39.01 |  | 41.84 |
| 1 month | 37.64 | | 42.81 |
| Current year | 27.68 | | 42.81 |
| 1 year | 15.91 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/7/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 22/6/26 | Fiscal year | Chief Executive Officer | 3,146,355 | 2.5806% | ||
| 11/6/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.50% | -2.71% | +144.35% | +63.00% | 4.77B | |
| -2.73% | -2.96% | +48.62% | +147.27% | 1,023B | |
| -1.67% | -3.47% | +52.00% | +47.77% | 599B | |
| -0.44% | +2.17% | +33.88% | +78.20% | 448B | |
| -0.15% | +1.25% | +29.54% | +20.58% | 326B | |
| +3.01% | +3.56% | +38.48% | +38.91% | 278B | |
| +0.57% | +0.63% | +21.60% | +15.52% | 258B | |
| -1.04% | +2.08% | -20.58% | -41.16% | 222B | |
| -0.58% | +1.03% | +23.55% | +56.14% | 197B | |
| -0.80% | +1.38% | +23.09% | +66.64% | 165B | |
| Average | -0.15% | -0.62% | +39.45% | +49.29% | 351.98B | |
| Weighted average by Cap. | +0.33% | -1.19% | +35.95% | +70.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.1B 1.02B 939M 1.77B 122B 1.8B 12.21B 4.79B 59.45B 4.73B 4.63B 205B | 1.31B 1.15B 1.06B 978M 1.85B 127B 1.87B 12.71B 4.98B 61.92B 4.93B 4.82B 213B |
| Net income | 414M 363M 336M 309M 583M 39.97B 592M 4.02B 1.57B 19.56B 1.56B 1.52B 67.37B | 473M 414M 383M 352M 665M 45.6B 675M 4.58B 1.8B 22.31B 1.78B 1.74B 76.87B |
| Net Debt | 54.5M 47.77M 44.16M 40.61M 76.62M 5.26B 77.85M 528M 207M 2.57B 205M 200M 8.86B | -403M -354M -327M -301M -567M -38.9B -576M -3.91B -1.53B -19.03B -1.51B -1.48B -65.58B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | USD 39.12 | -3.50% | 2,540,765 |
| 17/07/26 | USD 40.54 | -0.12% | 984,698 |
| 16/07/26 | USD 40.59 | -0.83% | 1,746,666 |
| 15/07/26 | USD 40.93 | +1.74% | 1,870,240 |
| 14/07/26 | USD 40.23 | +0.05% | 992,052 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition